BlueCross BlueShield of South Carolina wants to help our members choose drug therapies that are both affordable and effective, especially for the treatment of chronic health conditions. Effective March 15, 2015, we cover Viekira exclusively as the all-oral drug therapy for treatment of Hepatitis C. This change is in effect for all individual and small group grandfathered and non-grandfathered plans. It also affects all chamber 51+ plans. It does not impact BlueEssentials plans and Business BlueEssentials plans (those sold on the public and private Marketplace).
We will exclude a similar drug, Harvoni, from our coverage. Members who started therapy on Harvoni prior to March 15, however, will be grandfathered and can complete their treatments. In addition, an exception process is available to members who have a unique medical need for Harvoni.
The purpose of this notice is to inform you which plans are affected by this change in prescription drug coverage.